Streptokinase biosimilar (Shasun Chemicals & Drugs)

链激酶生物类似药 (Shasun Chemicals & Drugs)

Report date: 2022/02/11 11:15:54

Base Information

Drug NameStreptokinase biosimilar (Shasun Chemicals & Drugs)

Drug Alias Name链激酶生物仿制药 (Shasun Chemicals & Drugs)KlotbusterLupiflo

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar

Mechanisms of ActionPlasminogen activators

TargetsPlasminogen

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsCardiovascular Diseases

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2009/07/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesShasun Chemicals & Drugs

China Registration ClassN/A

Develop Information

Active CompaniesShasun Chemicals & Drugs

Inactive CompaniesN/A

Active IndicationsCardiovascular Diseases

Inactive IndicationsN/A

Other Information

ATC CodeB01AD01